Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Data on immunization described by researchers at Erasmus Medical Center, Department of Virology
March 26th, 2008
A new study, 'Vaccination approaches to combat human metapneumovirus lower respiratory tract infections,' is now available. "Human metapneumovirus (hMPV) was discovered in 2001 as a causative agent of respiratory disease in young children, immunocompromised individuals and the elderly. Clinical signs of hMPV infection range from mild respiratory illness to bronchiolitis and pneumonia," scientists writing in the Journal of Clinical Virology report. "Two main genetic lineages of hMPV that circulate worldwide were found to be antigenically different, but antibodies against the F protein, the major determinant of protection, were shown to be cross-protective. Since...
Source: Vaccine Weekly (2008-03-26)
|
